Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 477-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of an Extended 4‐hour Infusion of Piperacillin‐Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 6, 2015-06 ,pp. : 600-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia

By Boselli Emmanuel   Breilh Dominique   Cannesson Maxime   Xuereb Fabien   Rimmelé Thomas   Chassard Dominique   Saux Marie-Claude   Allaouchiche Bernard  

Intensive Care Medicine, Vol. 30, Iss. 5, 2004-05 ,pp. : 976-979

Springer Publishing Company

Access to resources Recommend Favorite

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 4, 2014-10 ,pp. : 438-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetics and pharmacodynamics of dalfampridine-ER in healthy volunteers and in patients with multiple sclerosis

By Weir Scott   Gao Yuying   Henney Herbert R.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1637-1645

Informa Healthcare

Access to resources Recommend Favorite